Open-Label Extension Study of DCCR in PWS Followed by Double-Blind, Placebo-Controlled, Randomized Withdrawal Period

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This is a multi-center, multi-period study with an open-label period followed by a double-blind, placebo-controlled, randomized withdrawal period evaluating the safety and efficacy of DCCR treatment.
Epistemonikos ID: 33a0e15fa88b44829caef934a9d4495668beb39f
First added on: May 21, 2024